Correlation Between Senti Biosciences and Lipella Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Senti Biosciences and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Senti Biosciences and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and Lipella Pharmaceuticals.

Diversification Opportunities for Senti Biosciences and Lipella Pharmaceuticals

-0.79

Correlation Coefficient

Senti Biosciences  Lipella Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Senti and Lipella is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and Lipella Pharmaceuticals go up and down completely randomly.

Pair Corralation between Senti Biosciences and Lipella Pharmaceuticals

Given the investment horizon of 90 days Senti Biosciences is expected to under-perform the Lipella Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Senti Biosciences is 1.59 times less risky than Lipella Pharmaceuticals. The stock trades about -0.18 of its potential returns per unit of risk. The Lipella Pharmaceuticals Common is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest  246.00  in Lipella Pharmaceuticals Common on May 6, 2025 and sell it today you would lose (81.00) from holding Lipella Pharmaceuticals Common or give up 32.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	53.23%
Values	Daily Returns

Senti Biosciences  vs.  Lipella Pharmaceuticals Common

Senti Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Senti Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in September 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Lipella Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lipella Pharmaceuticals Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in September 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Senti Biosciences and Lipella Pharmaceuticals

The main advantage of trading using opposite Senti Biosciences and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.

The idea behind Senti Biosciences and Lipella Pharmaceuticals Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.